(Reuters) - Eli Lilly and Co said on Tuesday it would spin off its Elanco animal health business and take it public.
Lilly will retain a stake of less than 20 percent and expects to complete the initial public offering during the second half of the year, the company said in a statement.
(Reporting by Tamara Mathias in Bengaluru; Editing by Supriya Kurane)
Disclaimer: No Business Standard Journalist was involved in creation of this content
